Ramage JM - Search Results

1

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

Watson NF, Ramage JM, Madjd Z, Spendlove I, Ellis IO, Scholefield JH, Durrant LG. Watson NF, et al. Among authors: ramage jm. Int J Cancer. 2006 Jan 1;118(1):6-10. doi: 10.1002/ijc.21303. Int J Cancer. 2006. PMID: 16003753

2

Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice.

Ramage JM, Metheringham R, Moss R, Spendlove I, Rees R, Durrant LG. Ramage JM, et al. Vaccine. 2004 Apr 16;22(13-14):1728-31. doi: 10.1016/j.vaccine.2004.01.034. Vaccine. 2004. PMID: 15068856

3

Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2.

Ramage JM, Metheringham R, Conn A, Spendlove I, Moss RS, Patton DT, Murray JC, Rees RC, Durrant LG. Ramage JM, et al. Int J Cancer. 2004 Jun 10;110(2):245-50. doi: 10.1002/ijc.20120. Int J Cancer. 2004. PMID: 15069689

4

Development of cancer vaccines to activate cytotoxic T lymphocytes.

Durrant LG, Ramage JM. Durrant LG, et al. Among authors: ramage jm. Expert Opin Biol Ther. 2005 Apr;5(4):555-63. doi: 10.1517/14712598.5.4.555. Expert Opin Biol Ther. 2005. PMID: 15934833 Review.

5

The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2.

Ramage JM, Spendlove I, Rees R, Moss RS, Durrant LG. Ramage JM, et al. Cancer Immunol Immunother. 2006 Aug;55(8):1004-10. doi: 10.1007/s00262-005-0119-1. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408213 Free PMC article.

6

Complement decay accelerating factor (DAF)/CD55 in cancer.

Spendlove I, Ramage JM, Bradley R, Harris C, Durrant LG. Spendlove I, et al. Among authors: ramage jm. Cancer Immunol Immunother. 2006 Aug;55(8):987-95. doi: 10.1007/s00262-006-0136-8. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485129 Free PMC article.

7

Costimulation via CD55 on human CD4+ T cells mediated by CD97.

Capasso M, Durrant LG, Stacey M, Gordon S, Ramage J, Spendlove I. Capasso M, et al. J Immunol. 2006 Jul 15;177(2):1070-7. doi: 10.4049/jimmunol.177.2.1070. J Immunol. 2006. PMID: 16818763

8

DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cells.

Pudney VA, Metheringham RL, Gunn B, Spendlove I, Ramage JM, Durrant LG. Pudney VA, et al. Among authors: ramage jm. Eur J Immunol. 2010 Mar;40(3):899-910. doi: 10.1002/eji.200939857. Eur J Immunol. 2010. PMID: 20039301 Free article.

9

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

Popple A, Durrant LG, Spendlove I, Rolland P, Scott IV, Deen S, Ramage JM. Popple A, et al. Among authors: ramage jm. Br J Cancer. 2012 Mar 27;106(7):1306-13. doi: 10.1038/bjc.2012.49. Epub 2012 Mar 13. Br J Cancer. 2012. PMID: 22415233 Free PMC article.

10

CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.

Sutavani RV, Bradley RG, Ramage JM, Jackson AM, Durrant LG, Spendlove I. Sutavani RV, et al. Among authors: ramage jm. J Immunol. 2013 Dec 15;191(12):5895-903. doi: 10.4049/jimmunol.1301458. Epub 2013 Nov 6. J Immunol. 2013. PMID: 24198281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters